Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1042.84%
operating margin TTM
-1050.83%
revenue TTM
7.90 Million
revenue per share TTM
0.21$
valuation ratios | |
|---|---|
| pe ratio | -2.34 |
| peg ratio | 0.33 |
| price to book ratio | 1.05 |
| price to sales ratio | 27.09 |
| enterprise value multiple | -3.66 |
| price fair value | 1.05 |
profitability ratios | |
|---|---|
| gross profit margin | -551.47% |
| operating profit margin | -1050.83% |
| pretax profit margin | -1042.84% |
| net profit margin | -1042.84% |
| return on assets | -40.59% |
| return on equity | -39.16% |
| return on capital employed | -43.87% |
liquidity ratio | |
|---|---|
| current ratio | 14.33 |
| quick ratio | 14.33 |
| cash ratio | 6.30 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 201.78 |
| days of payables outstanding | 22.24 |
| cash conversion cycle | 179.54 |
| receivables turnover | 1.81 |
| payables turnover | 16.42 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | -1,911.24 |
| cash flow to debt ratio | -21.72 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.82 |
| cash per share | 4.33 |
| operating cash flow per share | -1.80 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -21.72 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -66.58 |
Frequently Asked Questions
When was the last time Molecular Partners AG (NASDAQ:MOLN) reported earnings?
Molecular Partners AG (MOLN) published its most recent earnings results on 30-09-2024.
What is Molecular Partners AG's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Molecular Partners AG (NASDAQ:MOLN)'s trailing twelve months ROE is -39.16%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Molecular Partners AG (MOLN) currently has a ROA of -40.59%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MOLN's net profit margin stand at?
MOLN reported a profit margin of -1042.84% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MOLN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 14.33 in the most recent quarter. The quick ratio stood at 14.33, with a Debt/Eq ratio of 0.02.